|
|
Clinical Trials
Clinical Trials
A Phase I/II, Multicenter, Open-Label, Noncomparative Study of the International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) Group to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Raltegravir (Isentress™, MK-0518) in HIV-1 Infected Children and Adolescents IMPAACT P1066
Keywords: HIV, Raltegravir in HIV-infected children, teens | A Phase II Safety and Immunogenicity Study of Quadrivalent Human Papilloma Virus [TYPES 6, 11, 16, 18] L1 Virus-Like Particle [VLP] Vaccine (GARDASIL®) in HIV-Infected Children (greater or equal to) 7 TO < 12 Years of Age P1047-Version 1.0
Keywords: HIV, HPV vaccine | A Prospective, Open-Label Study to Assess the Pharmacokinetics, Safety and Efficacy of Anidulafungin When Used to Treat Children with Invasive Candidiasis, Including Candidemia (A8851008)
Keywords: Fungal Infection, Invasive candidiasis | A5240: A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Keywords: HPV, HIV, vaccination | A5257: A Phase III Comparative Study of Three Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Sparing Antiretroviral Regimens for Treatment-Naïve HIV-1-Infected Volunteers (The ARDENT Study: Atazanavir, Raltegravir, or Darunavir with Emtricitabine/Tenofovir for Naïve Treatment)
Keywords: HIV infected women; HIV medication study | An open label, prospective, pharmacokinetic/pharmacodynamic and safety evaluation of intravenous oseltamivir (Tamiflu) in the treatment of children 1 to 12 years of age with influenza infection (NP24139C)
Keywords: Influenza | An open label, prospective, pharmacokinetic/pharmacodynamic and safety evaluation of intravenous oseltamivir (Tamiflu®) in the treatment of infants less than one year of age with influenza infection
(Protocol NP25138)
Keywords: influenza, infants | An Open-label, Multicenter, Multiple-dose Pharmacokinetic and 48-week Safety and Efficacy Trial of Marairoc in Combination with Optimized Background Therapy for the Treatment of Antiretroviral-experienced CCR5-tropic HIV-1 Infected Children 2-18 Years of Age (A4001031)
Keywords: HIV, maraviroc | CASG112: A Phase III Randomized, Placebo-Controlled Blinded Investigation of Six Weeks vs. Six Months of Oral Valganciclovir Therapy in Infants with Symptomatic Congenital Cytomegalovirus Infection
Keywords: Infection, Cytomegalovirus infection, Neonates | IMPAACT P1065: Phase I/II, Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV-4) In HIV-Infected Children and Youth.
Keywords: HIV, meningococcal conjugate vaccine, children, youth | IMPACCT 1077 HS: HAART Standard Version of the PROMISE Study (Promoting Maternal and Infant Survival Everywhere), Version 1.0
Keywords: HIV, post partum | Newborn Evaluation for Effects of Maternal Tenofovir Use During Preganancy (PHACS PH101)
A Multi-Center Substudy of the Pediatric HIV/AIDS-Cohort Study (PHACS) Surveillance Monitoring for ART Toxicities Study in HIV-uninfected Children Born to HIV-Infected Women (SMARTT) Protocol
Keywords: HIV, antiretrovirals | P1074: A Prospective Surveillance Study of Long-Term Outcomes in HIV-infected Infants, Children and Adolescents, Version 1.0 dated February 2, 2009
The IRB has determined the risk/benefit for this study is consistent with 45 CFR 46.404.
Keywords: HIV, long-term outcomes, chart review | PACTG P1055: Psychiatric Co-Morbidity in Perinatally HIV-Infected Children and Adolescents
Keywords: HIV, children, Psychiatric | Perinatal Core Protocol, PACTG 1025
Includes Substudy: IMPAACT P1026s: Pharmacokinetic Properties of Antiretroviral Drugs During Pregnancy
Keywords: HIV | Pharmacotherapy for Hazardous Drinking in HIV Infected Women: Randomized Trial
Keywords: Hazardous Drinking Behavior, HIV, alcohol, naltrexone | Strategic timing of antiretroviral treatment (START), a multicenter study of the international network for strategic initiatives in global HIV trials (INSIGHT)
Keywords: AIDS, antiretrovirals, ART | Surveillance Monitoring for ART Toxicities Study in HIV-uninfected Children Born to HIV-infected Women (SMARTT study) (PH100)
Keywords: HIV |
All Research
A Phase I/II, Multicenter, Open-Label, Noncomparative Study of the International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) Group to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Raltegravir (Isentress™, MK-0518) in HIV-1 Infected Children and Adolescents IMPAACT P1066
Keywords: HIV, Raltegravir in HIV-infected children, teens | A Phase II Safety and Immunogenicity Study of Quadrivalent Human Papilloma Virus [TYPES 6, 11, 16, 18] L1 Virus-Like Particle [VLP] Vaccine (GARDASIL®) in HIV-Infected Children (greater or equal to) 7 TO < 12 Years of Age P1047-Version 1.0
Keywords: HIV, HPV vaccine | A Prospective, Open-Label Study to Assess the Pharmacokinetics, Safety and Efficacy of Anidulafungin When Used to Treat Children with Invasive Candidiasis, Including Candidemia (A8851008)
Keywords: Fungal Infection, Invasive candidiasis | A Retrospective Chart Review On Cases Of Lemierre's Syndrome In A Tertiary Care Children's Hospital
Keywords: Lemierre's Syndrome | A5240: A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Keywords: HPV, HIV, vaccination | A5257: A Phase III Comparative Study of Three Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Sparing Antiretroviral Regimens for Treatment-Naïve HIV-1-Infected Volunteers (The ARDENT Study: Atazanavir, Raltegravir, or Darunavir with Emtricitabine/Tenofovir for Naïve Treatment)
Keywords: HIV infected women; HIV medication study | Aging And HIV: Health And Psychosocial Status And Needs Of Older Individuals With HIV
Keywords: HIV, focus group | An open label, prospective, pharmacokinetic/pharmacodynamic and safety evaluation of intravenous oseltamivir (Tamiflu) in the treatment of children 1 to 12 years of age with influenza infection (NP24139C)
Keywords: Influenza | An open label, prospective, pharmacokinetic/pharmacodynamic and safety evaluation of intravenous oseltamivir (Tamiflu®) in the treatment of infants less than one year of age with influenza infection
(Protocol NP25138)
Keywords: influenza, infants | An Open-label, Multicenter, Multiple-dose Pharmacokinetic and 48-week Safety and Efficacy Trial of Marairoc in Combination with Optimized Background Therapy for the Treatment of Antiretroviral-experienced CCR5-tropic HIV-1 Infected Children 2-18 Years of Age (A4001031)
Keywords: HIV, maraviroc | CASG112: A Phase III Randomized, Placebo-Controlled Blinded Investigation of Six Weeks vs. Six Months of Oral Valganciclovir Therapy in Infants with Symptomatic Congenital Cytomegalovirus Infection
Keywords: Infection, Cytomegalovirus infection, Neonates | Cost-Effectiveness of Routine Active Surveillance for Methicillin-Resistant Staphylococcus Aureus Colonization in the Neonatal Intensive Care Unit
Keywords: | Diagnostic Value of Serum Procalcitonin in Mycoplasma Pneumoniae Infections During Severe Asthma
Keywords: Mycoplasma pneumoniae | IMPAACT P1065: Phase I/II, Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV-4) In HIV-Infected Children and Youth.
Keywords: HIV, meningococcal conjugate vaccine, children, youth | IMPACCT 1077 HS: HAART Standard Version of the PROMISE Study (Promoting Maternal and Infant Survival Everywhere), Version 1.0
Keywords: HIV, post partum | METHICILLIN–RESISTANT STAPHYLOCOCCUS AUREUS NASAL COLONIZATION AND SUBSEQUENT INFECTION IN A LEVEL III NEONATAL INTENSIVE CARE UNIT
Keywords: Infection, MRSA, NICU | Newborn Evaluation for Effects of Maternal Tenofovir Use During Preganancy (PHACS PH101)
A Multi-Center Substudy of the Pediatric HIV/AIDS-Cohort Study (PHACS) Surveillance Monitoring for ART Toxicities Study in HIV-uninfected Children Born to HIV-Infected Women (SMARTT) Protocol
Keywords: HIV, antiretrovirals | P1074: A Prospective Surveillance Study of Long-Term Outcomes in HIV-infected Infants, Children and Adolescents, Version 1.0 dated February 2, 2009
The IRB has determined the risk/benefit for this study is consistent with 45 CFR 46.404.
Keywords: HIV, long-term outcomes, chart review | PACTG P1055: Psychiatric Co-Morbidity in Perinatally HIV-Infected Children and Adolescents
Keywords: HIV, children, Psychiatric | Perinatal Core Protocol, PACTG 1025
Includes Substudy: IMPAACT P1026s: Pharmacokinetic Properties of Antiretroviral Drugs During Pregnancy
Keywords: HIV | Pharmacotherapy for Hazardous Drinking in HIV Infected Women: Randomized Trial
Keywords: Hazardous Drinking Behavior, HIV, alcohol, naltrexone | Posterior Scleritis in Children: A Ten Year Review
Keywords: Posterior scleritis | START: Strategic Timing of AntiRetroviral Treatment; INSIGHT 001; Version 2.0
Keywords: Antiretroviral treatment | Strategic timing of antiretroviral treatment (START), a multicenter study of the international network for strategic initiatives in global HIV trials (INSIGHT)
Keywords: AIDS, antiretrovirals, ART | Surveillance Monitoring for ART Toxicities Study in HIV-uninfected Children Born to HIV-infected Women (SMARTT study) (PH100)
Keywords: HIV | The Prevalence of Methacillin-Resistant Staphylococcus aureus Nasal Colonization and Subsequent Infection in a Pediatric Intensive Care Unit
Keywords: Hospital Infection, MRSA, PICU | Vitamin D and Calcium Deficiency in HIV Infected Children and Adolescents
Keywords: Vitamin D, HIV infection, AIDS, calcium |
|
|
